Photobiomodulation for Dry Age Related Macula Degeneration
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorOslo University Hospital
About this trial
The study will investigate the effect of photobiomodulation treatment on the risk of developing late age related macula degeneration (AMD) in the study eye in patients with wet AMD in the fellow eye.
Eligibility criteria
Qualifiers
patients with dry AMD in the study eye and wet AMD in the control eye
Disqualifiers
Geographic atrophy of the central macular region at enrolment
Previous/ active wet AMD in the study eye
A history of epilepsy
Retinal diseases apart from AMD
Trial design
Treatments tested in this trial
- Valeda machine
Treatment groups
121 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov